Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • Power of Women 2024
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Patent Rights

He would ransom the pills for something more precious than profit: His wife’s life
Article
/ 15 February 2019

He would ransom the pills for something more precious than profit: His wife’s life

When a few months of treatment costs as much as a house, some patients are taking their lives and the law into their own hands to survive.

By Joan Van Dyk
Hundreds of protestors descend on DTI’s Pretoria offices demanding access to affordable medicines
Article
/ 27 September 2016

Hundreds of protestors descend on DTI’s Pretoria offices demanding access to affordable medicines

Think paying your medical aid premiums every month ensures you access to the drugs you need when you get sick? Think again.

By Staff Reporter
Lift the veil on drug pricing and trade agreements, the UN urges companies and states
Article
/ 14 September 2016

Lift the veil on drug pricing and trade agreements, the UN urges companies and states

New United Nations report calls for drug companies to spill closely held secrets and patent reforms.

By Laura Lopez Gonzalez
No image available
Article
/ 12 November 2015

Bhekisisa’s stories changing lives: ‘People were finally helping me’

A TB patient finally gets a disability grant and a woman has free access to the world’s most expensive drug.

By Amy Green
No image available
Article
/ 3 December 2014

Activists fear a pharmaceutical plot is at play

The department of trade and industry has yet to finalise patent reforms, raising questions that cheaper medication could be blocked intentionally.

By Amy Green
New drug policy is patently high risk
Article
/ 30 October 2014

New drug policy is patently high risk

There is widespread support for drastic change to patent laws when it comes to pharmaceuticals, but the results could be disastrous.

By Phillip De Wet and Sarah Wild
Big pharma companies seek higher profits by cleaning out their medicine chests
Article
/ 5 May 2014

Big pharma companies seek higher profits by cleaning out their medicine chests

Global pharma companies are looking to sell off their mature drugs, which are often sold in emerging markets where governments demand low prices.

By Reuters
Patients before patents, demand health activists
Article
/ 11 March 2014

Patients before patents, demand health activists

The intellectual property policy, which will allow access to cheaper drugs, has yet to be finalised while patients are dying, say health activists.

By Amy Green and Bhekisisa Team
No image available
Article
/ 11 October 2013

Brazil’s sick of patent exploitation

The country is fighting the intellectual property laws that hiked up the cost of its HIV programme.

By Mara Kardas-Nelson
Generic cancer drug – access not guaranteed
Article
/ 9 September 2013

Generic cancer drug – access not guaranteed

A generic version of a key cancer drug is now available in South Africa, but at a significantly higher cost than it is available internationally.

By Mara Kardas-Nelson
India makes breakthrough drug patent ruling against Novartis
Article
/ 1 April 2013

India makes breakthrough drug patent ruling against Novartis

India’s Supreme Court has rejected a patent bid by Novartis in a ruling that will protect access to generics and save lives in developing countries.

By Penny Macrae
No image available
Article
/ 20 September 2011

Samsung aims to ban iPhone 5 sales, say reports

Reports say Samsung will file lawsuits to try to block the sale of Apple’s iPhone 5 as part of its global legal tussle with the US technology giant.

By Staff Reporter

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }